←Back to Expert Scholars
Translational Medicine / 转化医学KRAS Combination Therapy
Adrian Sacher
MD
🏢Princess Margaret Cancer Centre🌐Canada
Medical Oncologist
35
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Adrian Sacher has led clinical trials of next generation KRAS G12C inhibitors including divarasib and early combination studies. His work defines efficacy and safety of KRAS targeted combinations in lung cancer. He contributes to global development of KRAS inhibitor regimens.
Share:
🧪Research Fields 研究领域
lung cancer
KRAS G12C
divarasib
combination therapy
clinical trials
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Adrian Sacher 的研究动态
Follow Adrian Sacher's research updates
留下邮箱，当我们发布与 Adrian Sacher（Princess Margaret Cancer Centre）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment